Erasca Inc (ERAS)
2.63
+0.04
(+1.54%)
USD |
NASDAQ |
May 24, 16:00
2.62
-0.01
(-0.38%)
After-Hours: 20:00
Erasca Shareholders Equity (Quarterly): 288.41M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 288.41M |
| December 31, 2023 | 316.69M |
| September 30, 2023 | 338.98M |
| June 30, 2023 | 362.70M |
| March 31, 2023 | 386.45M |
| December 31, 2022 | 411.85M |
| September 30, 2022 | 365.32M |
| Date | Value |
|---|---|
| June 30, 2022 | 395.07M |
| March 31, 2022 | 424.66M |
| December 31, 2021 | 456.53M |
| September 30, 2021 | 482.99M |
| June 30, 2021 | -150.00M |
| March 31, 2021 | -129.26M |
| December 31, 2020 | -113.98M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-150.00M
Minimum
Jun 2021
482.99M
Maximum
Sep 2021
274.03M
Average
364.01M
Median
Shareholders Equity (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | 16.49B |
| Exelixis Inc | 2.128B |
| Geron Corp | 344.87M |
| Verastem Inc | 46.22M |
| Karyopharm Therapeutics Inc | -168.96M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 370.02M |
| Total Liabilities (Quarterly) | 81.61M |